hVIVO (HVO) Competitors GBX 9.93 +0.18 (+1.79%) As of 07:48 AM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlinesBuy This Stock HVO vs. VRP, AVCT, FARN, ARIX, CIR, 4BB, BVXP, TILS, VSN, and MPHShould you be buying hVIVO stock or one of its competitors? The main competitors of hVIVO include Verona Pharma plc (VRP.L) (VRP), Avacta Group (AVCT), Faron Pharmaceuticals Oy (FARN), Arix Bioscience (ARIX), Circassia Group (CIR), 4basebio (4BB), Bioventix (BVXP), Tiziana Life Sciences (TILS), Verseon (VSN), and Mereo BioPharma Group plc (MPH.L) (MPH). These companies are all part of the "biotechnology" industry. hVIVO vs. Its Competitors Verona Pharma plc (VRP.L) Avacta Group Faron Pharmaceuticals Oy Arix Bioscience Circassia Group 4basebio Bioventix Tiziana Life Sciences Verseon Mereo BioPharma Group plc (MPH.L) Verona Pharma plc (VRP.L) (LON:VRP) and hVIVO (LON:HVO) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, valuation, analyst recommendations, institutional ownership, media sentiment, profitability, risk and earnings. Do analysts recommend VRP or HVO? hVIVO has a consensus price target of GBX 28, indicating a potential upside of 182.12%. Given hVIVO's stronger consensus rating and higher probable upside, analysts plainly believe hVIVO is more favorable than Verona Pharma plc (VRP.L).Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Verona Pharma plc (VRP.L) 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00hVIVO 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is VRP or HVO more profitable? hVIVO has a net margin of 25.96% compared to Verona Pharma plc (VRP.L)'s net margin of 0.00%. hVIVO's return on equity of 47.93% beat Verona Pharma plc (VRP.L)'s return on equity.Company Net Margins Return on Equity Return on Assets Verona Pharma plc (VRP.L)N/A N/A N/A hVIVO 25.96%47.93%11.97% Which has stronger valuation and earnings, VRP or HVO? hVIVO has higher revenue and earnings than Verona Pharma plc (VRP.L). Verona Pharma plc (VRP.L) is trading at a lower price-to-earnings ratio than hVIVO, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVerona Pharma plc (VRP.L)N/AN/AN/A-£32.70N/AhVIVO£62.73M1.09£17.84M£0.02640.32 Do insiders & institutionals believe in VRP or HVO? 4.6% of hVIVO shares are held by institutional investors. 4.4% of hVIVO shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Does the media prefer VRP or HVO? In the previous week, hVIVO had 1 more articles in the media than Verona Pharma plc (VRP.L). MarketBeat recorded 1 mentions for hVIVO and 0 mentions for Verona Pharma plc (VRP.L). hVIVO's average media sentiment score of 0.75 beat Verona Pharma plc (VRP.L)'s score of 0.00 indicating that hVIVO is being referred to more favorably in the news media. Company Overall Sentiment Verona Pharma plc (VRP.L) Neutral hVIVO Positive SummaryhVIVO beats Verona Pharma plc (VRP.L) on 13 of the 13 factors compared between the two stocks. Get hVIVO News Delivered to You Automatically Sign up to receive the latest news and ratings for HVO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding HVO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HVO vs. The Competition Export to ExcelMetrichVIVOBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£68.21M£237.68M£5.78B£2.56BDividend Yield2.06%3.78%5.74%5.31%P/E Ratio640.3233.2276.715,417.61Price / Sales1.094,879.29512.5797,495.16Price / Cash4.9413.1937.1727.93Price / Book1.79133.3713.669.11Net Income£17.84M-£90.99M£3.29B£5.89B7 Day Performance2.32%0.03%1.55%0.60%1 Month Performance-1.15%18.88%6.81%3.18%1 Year Performance-66.13%762.16%79.53%188.62% hVIVO Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HVOhVIVO1.8472 of 5 starsGBX 9.93+1.8%GBX 28+182.1%-66.1%£68.21M£62.73M640.32N/AVRPVerona Pharma plc (VRP.L)N/AN/AN/AN/A£228MN/A-1.6822Gap UpAVCTAvacta GroupN/AGBX 55+1.9%N/A-17.3%£220.97M£113K-358.54120FARNFaron Pharmaceuticals OyN/AGBX 190-1.3%N/A-17.4%£212.71MN/A-703.7034ARIXArix BioscienceN/AN/AN/AN/A£183.73M£14.16M1,290.919CIRCircassia GroupN/AN/AN/AN/A£142.66M£27.90M3,400.00111Gap Down4BB4basebio1.5204 of 5 starsGBX 880+2.9%GBX 1,600+81.8%-39.9%£136.27M£933K-936.17101High Trading VolumeBVXPBioventixN/AGBX 2,440-0.4%N/A-33.2%£127.49M£13.66M1,647.3112TILSTiziana Life SciencesN/AN/AN/AN/A£113.85M-£3.60M-3.5911Positive NewsVSNVerseonN/AN/AN/AN/A£112.24MN/A-5.17N/AGap UpMPHMereo BioPharma Group plc (MPH.L)N/AN/AN/AN/A£89.76MN/A-0.2150Gap Down Related Companies and Tools Related Companies VRP Competitors AVCT Competitors FARN Competitors ARIX Competitors CIR Competitors 4BB Competitors BVXP Competitors TILS Competitors VSN Competitors MPH Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:HVO) was last updated on 9/19/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding hVIVO plc Please log in to your account or sign up in order to add this asset to your watchlist. Share hVIVO With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
